Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Apr;29(4):403–412. doi: 10.1111/j.1365-2125.1990.tb03657.x

The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers.

L F Prescott 1, P Mattison 1, D G Menzies 1, L M Manson 1
PMCID: PMC1380109  PMID: 2183866

Abstract

1. Renal function was assessed in 10 healthy female volunteers during administration of placebo, paracetamol (acetaminophen) (4.0 g daily) and indomethacin (150 mg daily) for 3 days under conditions of controlled sodium and fluid intake. 2. Paracetamol and indomethacin had no significant effect on the glomerular filtration rate and effective renal plasma flow as measured by the renal clearances of inulin, creatinine and p-aminohippurate (PAH). 3. Compared with placebo, paracetamol reduced the mean urinary excretion of prostaglandin E2 by 43% on the second day and 58% on the third treatment day (P less than 0.01). With indomethacin the corresponding reductions were 73 and 80%. Paracetamol and indomethacin had much less effect on the excretion of prostaglandin 6-keto F1 alpha, and a significant decrease was observed only on the third day. 4. The decreased urinary excretion of prostaglandin E2, produced by paracetamol was associated with a reduction in sodium excretion of more than 50% (P less than 0.01) and delay in the onset of diuresis following an acute water load. 5. The renal effects of paracetamol and indomethacin appear to differ. Although indomethacin reduced prostaglandin excretion more than paracetamol it had a similar effect on sodium excretion and less initial antidiuretic action. Unlike paracetamol, indomethacin also reduced basal plasma renin activity. 6. Paracetamol reduced the total body clearance of PAH and increased its plasma half-life. This effect could be attributed to inhibition of the acetylation of PAH by paracetamol. 7. In normal use paracetamol does not appear to have the adverse renal effects associated with the non-steroidal anti-inflammatory analgesics and further studies are required to establish the clinical significance of these findings.

Full text

PDF
403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angeli P., Gatta A., Caregaro L., Menon F., Sacerdoti D., Merkel C., Visoná A., Lusiani L., Pagnan A. Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin-aldosterone system in humans. Clin Pharmacol Ther. 1988 Aug;44(2):211–216. doi: 10.1038/clpt.1988.139. [DOI] [PubMed] [Google Scholar]
  2. Blackshear J. L., Napier J. S., Davidman M., Stillman M. T. Renal complications of nonsteroidal antiinflammatory drugs: identification and monitoring of those at risk. Semin Arthritis Rheum. 1985 Feb;14(3):163–175. doi: 10.1016/0049-0172(85)90035-6. [DOI] [PubMed] [Google Scholar]
  3. Carmichael J., Shankel S. W. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med. 1985 Jun;78(6 Pt 1):992–1000. doi: 10.1016/0002-9343(85)90223-2. [DOI] [PubMed] [Google Scholar]
  4. Dawborn J. K. Application of Heyrovsky's inulin method to automatic analysis. Clin Chim Acta. 1965 Jul;12(1):63–66. doi: 10.1016/0009-8981(65)90109-9. [DOI] [PubMed] [Google Scholar]
  5. Dupin J. P., Gravier D., Casadebaig F., Boisseau M. R., Bernard H. In vitro antiaggregant activity of paracetamol and derivatives. Thromb Res. 1988 May 1;50(3):437–447. doi: 10.1016/0049-3848(88)90273-3. [DOI] [PubMed] [Google Scholar]
  6. Edwards O. M., Edwards P., Huskisson E. C., Taylor R. T. Paracetamol and renal damage. Br Med J. 1971 Apr 10;2(5753):87–89. doi: 10.1136/bmj.2.5753.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gabriel R., Caldwell J., Hartley R. B. Acute tubular necrosis, caused by therapeutic doses of paracetamol? Clin Nephrol. 1982 Nov;18(5):269–271. [PubMed] [Google Scholar]
  8. Garella S., Matarese R. A. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine (Baltimore) 1984 May;63(3):165–181. doi: 10.1097/00005792-198405000-00003. [DOI] [PubMed] [Google Scholar]
  9. Grèen K., Drvota V., Vesterqvist O. Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins. 1989 Mar;37(3):311–315. doi: 10.1016/0090-6980(89)90001-4. [DOI] [PubMed] [Google Scholar]
  10. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  11. Harvison P. J., Egan R. W., Gale P. H., Christian G. D., Hill B. S., Nelson S. D. Acetaminophen and analogs as cosubstrates and inhibitors of prostaglandin H synthase. Chem Biol Interact. 1988;64(3):251–266. doi: 10.1016/0009-2797(88)90101-9. [DOI] [PubMed] [Google Scholar]
  12. Haylor J. Prostaglandin synthesis and renal function in man. J Physiol. 1980 Jan;298:383–396. doi: 10.1113/jphysiol.1980.sp013088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kimberly R. P., Sherman R. L., Mouradian J., Lockshin M. D. Apparent acute renal failure associated with therapeutic aspirin and ibuprofen administration. Arthritis Rheum. 1979 Mar;22(3):281–285. doi: 10.1002/art.1780220311. [DOI] [PubMed] [Google Scholar]
  14. Levin M. L. Patterns of tubulo-interstitial damage associated with nonsteroidal antiinflammatory drugs. Semin Nephrol. 1988 Mar;8(1):55–61. [PubMed] [Google Scholar]
  15. Mattammal M. B., Zenser T. V., Brown W. W., Herman C. A., Davis B. B. Mechanism of inhibition of renal prostaglandin production by acetaminophen. J Pharmacol Exp Ther. 1979 Sep;210(3):405–409. [PubMed] [Google Scholar]
  16. McMurtry R. J., Snodgrass W. R., Mitchell J. R. Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol. 1978 Oct;46(1):87–100. doi: 10.1016/0041-008x(78)90139-4. [DOI] [PubMed] [Google Scholar]
  17. Mohandas J., Marshall J. J., Duggin G. G., Horvath J. S., Tiller D. J. Differential distribution of glutathione and glutathione-related enzymes in rabbit kidney. Possible implications in analgesic nephropathy. Biochem Pharmacol. 1984 Jun 1;33(11):1801–1807. doi: 10.1016/0006-2952(84)90353-8. [DOI] [PubMed] [Google Scholar]
  18. Murray T. G., Stolley P. D., Anthony J. C., Schinnar R., Hepler-Smith E., Jeffreys J. L. Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med. 1983 Sep;143(9):1687–1693. [PubMed] [Google Scholar]
  19. Nusynowitz M. L., Forsham P. H. The antidiuretic action of acetaminophen. Am J Med Sci. 1966 Oct;252(4):429–435. doi: 10.1097/00000441-196610000-00008. [DOI] [PubMed] [Google Scholar]
  20. Oates J. A. Antagonism of antihypertensive drug therapy by nonsteroidal anti-inflammatory drugs. Hypertension. 1988 Mar;11(3 Pt 2):II4–II6. doi: 10.1161/01.hyp.11.3_pt_2.ii4. [DOI] [PubMed] [Google Scholar]
  21. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. doi: 10.1016/0090-6980(80)90144-6. [DOI] [PubMed] [Google Scholar]
  22. Prescott L. F. Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics. Drugs. 1982 Jan-Feb;23(1-2):75–149. doi: 10.2165/00003495-198223010-00004. [DOI] [PubMed] [Google Scholar]
  23. Prescott L. F. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs. 1983 Mar;25(3):290–314. doi: 10.2165/00003495-198325030-00002. [DOI] [PubMed] [Google Scholar]
  24. Radack K. L., Deck C. C., Bloomfield S. S. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987 Nov;107(5):628–635. doi: 10.7326/0003-4819-107-5-628. [DOI] [PubMed] [Google Scholar]
  25. Sandler D. P., Smith J. C., Weinberg C. R., Buckalew V. M., Jr, Dennis V. W., Blythe W. B., Burgess W. P. Analgesic use and chronic renal disease. N Engl J Med. 1989 May 11;320(19):1238–1243. doi: 10.1056/NEJM198905113201903. [DOI] [PubMed] [Google Scholar]
  26. Segasothy M., Suleiman A. B., Puvaneswary M., Rohana A. Paracetamol: a cause for analgesic nephropathy and end-stage renal disease. Nephron. 1988;50(1):50–54. doi: 10.1159/000185116. [DOI] [PubMed] [Google Scholar]
  27. Wilkinson R., James O. F., Roberts S. H., Morley A. R., Robson V. Plasma renin activity during the development of paracetamol (acetaminophen) induced acute renal failure in man. Clin Nephrol. 1979 Apr;11(4):196–201. [PubMed] [Google Scholar]
  28. Zenser T. V., Mattammal M. B., Herman C. A., Joshi S., Davis B. B. Effect of acetaminophen on prostaglandin E2 and prostaglandin F2alpha synthesis in the renal inner medulla of rat. Biochim Biophys Acta. 1978 Sep 6;542(3):486–495. doi: 10.1016/0304-4165(78)90378-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES